Ignite Creation Date:
2024-05-06 @ 7:58 PM
Last Modification Date:
2024-10-26 @ 3:18 PM
Study NCT ID:
NCT06205199
Status:
COMPLETED
Last Update Posted:
2024-01-24
First Post:
2023-12-17
Brief Title:
Analgesic Effect of Ropivacaine Combined With Hydromorphone for CSEA After Total Knee Arthroplasty
Sponsor:
Second Hospital of Jilin University
Organization:
Second Hospital of Jilin University
Study Overview
Official Title:
Analgesic Effect of Ropivacaine Hydrochloride Combined With Hydromorphone Hydrochloride for Combined Spinal-epidural Anesthesia After Total Knee Arthroplasty
Status:
COMPLETED
Status Verified Date:
2024-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of this study is to investigate the continuous analgesic effect and side effects of ropivacaine combined with hydromorphone for combined spinal-epidural anesthesiaCSEA after total knee arthroplasty and to explore its clinical application value To observe whether hydromorphone combined with ropivacaine can promote the rapid recovery of patients
Detailed Description:
For patients undergoing total knee arthroplasty different spinal anesthesia drugs were injected in the two groups The spinal anesthetic drugs injected in the hydromorphone group were hydromorphone 50 μg and ropivacaine 15 mg In the control group the spinal anesthetic was ropivacaine 15 mgThe differences in analgesia sedation and side effects between the hydromorphone group and the control group were analyzed by collecting various data at different times after anesthesia
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None